Table 5 Baseline characteristics of high-risk patients with permanent pacemaker and isolated pulmonary Candida spp. colonization without pre-existing pneumonia (cohort 3)
Antifungal therapy (n = 8) | No antifungal therapy (n = 12) | p value | |
|---|---|---|---|
Age (years) | 73 (65; 79) | 74 (69; 83) | 0.69 |
Cancer, n (%) | 0 (0) | 4 (30) | 0.12 |
SAPS II | 50 (46; 56) | 34 (29; 58) | 0.09 |
SOFA score | 10 (5; 11) | 4 (3; 7) | 0.08 |